InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.28
(
0.07%
)
US TECH 100
19,264.80
(
0.52%
)
Dow Jones
39,097.61
(
-0.05%
)
Brent Oil
86.73
(
1.90%
)
Bitcoin
63,305.15
(
1.13%
)
Post# of 252446
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: kamehameha post# 131274

Thursday, 11/17/2011 4:35:20 AM

Thursday, November 17, 2011 4:35:20 AM

Post# of 252446
But the program also has a third phase III trial - FISSION that will test 12 weeks of PSI-7977/RBV vs. 24 weeks of PEG-IFN/RBV in 500 treatment-naïve GT 2/3 patients. So not restricted to patients that can not tolerate INF.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up